0.15Open0.15Pre Close0 Volume39 Open Interest22.50Strike Price0.00Turnover166.29%IV31.00%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1024Delta0.0536Gamma115.27Leverage Ratio-0.0576Theta0.0002Rho11.80Eff Leverage0.0036Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet